Moderna price target drops, fintech Outperform, FDA hits tobacco

business people have a meeting about company statistics

Yahoo Finance's Brad Smith reviews Wednesday's trending stocks on Wealth.

Moderna's ( MRNA ) price target slashed to $38 from $70 by Morgan Stanley ( MS ), implying an 11% potential upside based on its last closing price. Analysts cite lowered 2025 revenue outlook and vaccine market competition.

Fintech leaders SoFi ( SOFI ) and Affirm ( AFRM ) have been initiated by William Blair in research coverage, and are currently both rated Outperform.

Tobacco stocks, such as British American Tobacco ( BTI ), Imperial Brands ( IMBBY ), and Philip Morris ( PM ), are under pressure after US Food and Drug Administration (FDA) announces a proposal to cap nicotine levels in cigarettes.

To watch more expert insights and analysis on the latest market action, check out more Wealth here .

This post was written by Josh Lynch

Related Videos

OK